Abstract
The angiopoietin-Tie2 system in endothelial cells is an important regulator of vasculogenesis and vascular integrity. High levels of angiopoietin-2 (Ang2) mRNA are observed in vascular activation during tumorigenesis. Although Ang2 is known to be a naturally occurring antagonist of angiopoietin-1 (Ang1) in vivo, the exact function of Ang2 itself is not known. Here, we found that a high concentration of Ang2 (800 ng/ml) acts as an apoptosis survival factor for endothelial cells during serum deprivation apoptosis. The survival effect of high concentration Ang2 was blocked by pre-treatment with soluble Tie2 receptor and the PI 3′-kinase-specific inhibitors, wortmannin and LY294002. Accordingly, 800 ng/ml of Ang2 induced phosphorylation of Tie2, the p85 subunit of phosphatidylinositol 3′-kinase (PI 3′-kinase), and serine-threonine kinase Akt at Ser473 in the human umbilical vein endothelial cells; lower concentrations of Ang2 (50–400 ng/ml) did not produce notable effects. These findings indicate that at high concentrations, Ang2, like Ang1, can be an apoptosis survival factor for endothelial cells through the activation of the Tie2 receptor, PI 3′-kinase and Akt, and thus may be a positive regulator of tumor angiogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD and Isner JM. . 1998 Circ. Res. 83: 233–240.
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S and Reed JC. . 1998 Science 282: 1318–1321.
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg MG. . 1997 Cell 91: 231–241.
Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC and Yancopoulos GD. . 1996 Cell 87: 1161–1169.
Dunk C, Shams M, Nijjar S, Rhaman M, Qiu Y, Bussolati B and Ahmed A. . 2000 Am. J. Pathol. 156: 2185–2199.
Hanahan D. . 1997 Science 277: 48–50.
Hanahan D and Folkman J. . (1996) Cell 86: 353–364.
Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD and Wiegand SJ. . 1999 Science 284: 1994–1998.
Kim I, Kim HG, So J-N, Kim JH, Kwak HJ and Koh GY. . 2000a Circ. Res. 86: 24–29.
Kim I, Kim J-H, Ryu YS, Jung SH, Nah JJ and Koh GY. . 2000b J. Biol. Chem. 275: 18550–18556.
Kim I, Moon S-O, Koh KN, Kim H, Uhm CS, Kwak HJ, Kim NG and Koh GY. . 1999 J. Biol. Chem. 274: 26523–26528.
Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U and Risau W. . 1998 Curr. Biol. 8: 529–532.
Kwak HJ, So J-N, Lee SJ, Kim I and Koh GY. . 1999 FEBS Lett. 448: 249–253.
Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN and Yancopoulos GD. . 1997 Science 277: 55–60.
Mandriota ST and Pepper MS. . 1998 Circ. Res. 83: 852–859.
Oh H, Takagi H, Suzuma K, Otani A, Matsumura M and Honda Y. . 1999 J. Biol. Chem. 274: 15732–15739.
Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, Altieri DC and Sessa WC. . 2000 J. Biol. Chem. 275: 9102–9105.
Papapetropoulos A, Garcia-Cardena G, Dengler TJ, Maisonpierre PC, Yancopoulos GD, and Sessa WC. . 1999 Lab. Invest. 79: 213–223.
Risau W. . 1995 FASEB J. 9: 926–933.
Risau W. . 1997 Nature 386: 671–674.
Shyu KG, Manor O, Magner M, Yancopoulos GD and Isner JM. . 1998 Circulation 98: 2081–2087.
Stratmann A, Risau W and Plate KH. . 1998 Am. J. Pathol. 153: 1459–1466.
Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN and Yancopoulos GD. . 1996 Cell 87: 1171–1180.
Suri C, McClain J, Thursyon G, McDonald DM, Zhou H, Oldmixon EH, Sato TN and Yancopoulos GD. . 1998 Science 282: 468–471.
Tanaka S, Mori M, Sakamoto Y, Makuuchi M, Sugimachi K and Wands JR. . 1999 J. Clin. Invest. 103: 341–345.
Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM and Yancopoulos GD. . 2000 Nat. Med. 6: 460–463.
Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD and McDonald DM. . 1999 Science 286: 2511–2514.
Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD and Isner JM. . 1998 J. Biol. Chem. 273: 18514–18521.
Acknowledgements
This work was supported by the Creative Research Initiatives of the Korean Ministry of Science and Technology. We thank PC Maisonpierre and GD Yancopoulos for providing Ang2 and rTie2-Fc reagents. We thank J Macke for help in preparing the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, I., Kim, JH., Moon, SO. et al. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene 19, 4549–4552 (2000). https://doi.org/10.1038/sj.onc.1203800
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203800
Keywords
This article is cited by
-
Angiogenic ability of human endothelial cells was decreased following senescence induction with hydrogen peroxide: possible role of vegfr-2/akt-1 signaling pathway
BMC Molecular and Cell Biology (2022)
-
The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2
Oncogene (2022)
-
Isopimpinellin extends antiangiogenic effect through overexpression of miR-15b-5p and downregulating angiogenic stimulators
Molecular Biology Reports (2022)
-
Angiopoietin-2-induced lymphatic endothelial cell migration drives lymphangiogenesis via the β1 integrin-RhoA-formin axis
Angiogenesis (2022)
-
Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders
Drugs (2021)